- A non-for-profit organisation registered in Brussels Belgium in March 2015
As a point of convergence on Brain Health
- for global leaders, key experts, leading multi-stakeholders (public institutions, private corporations…) and their constituents
- interested in working towards sustainable Brain Health Promotion as well as Brain Disorders & Cognitive Impairment Prevention
- SBHI is conducted by a Board of Directors from the Scientific, Business and Policy communities
- The "Founding Members", the Founders of this Association, set and validate the Association Plan and determine the rules of procedure of the Association. Members of the General Assembly with voting rights.
b- Board of Directors
The Board of Directors a group of international experts
- President, Professor François Boller, M.D., Ph.D., Neurologist and Professor of Neurology at the Department of Neurology of the George Washington University Medical School in Washington, DC USA
- Vice President, Methodology and Social Science Professor Anne-Marie Aish, Social Sciences London UK
- Vice President, Corporate Relationship Dr Charles Marciano PhD, Paris France
- Vice President Dr. Veronique Narboni MD, Paris France.
- Vice President, Scientific Education Professor Viviane Kovess Epidemiology Psychiatry, Paris France
- Vice President, European Affairs Ms Xenia Schneider, MBA, Strovolos, Cyprus
- Treasurer, Ms. Helen Bengtsson, Health & Medical Communications, London UK
- Secretary General and Executive Director, Ms. Pauline Harper, B.Comm, L.LB, Paris France
Viviane Kovess Masfety
Xénia Theodotou Schneider
is a Research Consultant in Quantitative Social Research and continues to teach specialised courses on different methodological issues.
She was Research Director at the Centre for Electoral Research of University of Louvain (Belgium) and Visiting Research Professor at NASP (the Swedish National Centre for Suicide Research and Prevention of Mental Ill-Health, Karolinska Institute, Stockholm).
She has been teaching Structural Equation Modeling at several European Universities (Brussels, Louvain, Essex, Budapest, Lille and Paris, at the Zentral Archive of the University of Cologne, the Karolinska Institute in Stockholm) and HK Universities (HKU, HKUST, City University).
She has offered methodological advice on a large number of research projects in different academic institutions. Anne-Marie Aish’s interests are both substantive and methodological. Her current interests cover mental health related problems and delinquency related problems, applicability issues in structural equation modeling, causal explanation in the social sciences, causal interpretation of statistically based results and measurement problems in cross-cultural research.
is a science graduate and has worked in healthcare all her life, in various roles including sales, advertising, marketing and communications.
She has a passion for delivering life-changing healthcare, working in partnerships to deliver integrated, strategic communications, through innovative multi-channel media to physicians, patients and payers.
Brain health has become increasingly important to Helen, as her family ages. She is excited to be involved with the Sustainable Brain Health Institute to help decrease the negative impact of brain disorders on society and make a difference for people across the globe.
has a background in Law and Business and over 23 years of experience at senior executive management levels in the communications sector, including leadership roles with Saatchi and Saatchi, BBDO and Publicis.
Most recently, she is Director Advisory for a Brussels-based non-governmental organisation created in 2011 for the prevention of childhood obesity across the globe.
She helped define its vision and ensure the alignment of its strategies with senior global public and private multi-stakeholders from leading health, nutrition and physical activity fields, as well as with educators, industry professionals and government officials in order to advance obesity and NCDs prevention efforts.
She is an expert in Public Private Partnerships Interfacing and Fundraising. She has participated in EU co-funded applied research projects. She is co-author of several publications on overweight and obesity prevention.
She is a Canadian who has resided in Paris, France since 1999 with her husband, Joseph Moussalli, a Gastroenterologist at La Pitié Salpétrière Hospital and her two children, Georges aged 14 and Gabrielle aged 9. She is fluent in English and French.
M.D., Ph.D., is Professor of Neurology at the Department of Neurology of the George Washington (GW) University Medical School in Washington, DC.
He was born in Switzerland and educated in Italy where he obtained a Medical Degree at the University of Pisa. After specializing in Neurology at the University of Milan, Dr. Boller spent several years at Boston University Medical School, including a Fellowship under the direction of Dr. Norman Geschwind.
He obtained a Ph.D. in Experimental Psychology from Case Western Reserve University, Cleveland OH where he was in charge of Neuroscience teaching at the Medical School and was nominated Teacher of the Year.
In 1983, Dr. Boller became Professor of Neurology and Psychiatry at the University of Pittsburgh where he founded and directed one of the first NIH funded Alzheimer Disease Research Centers in the country.
In 1989, he was put in charge of a Paris-based INSERM Unit dedicated to the neuropsychology and neurobiology of cerebral aging. He returned to the United States and joined the NIH in 2005, before coming to GW in July 2014.
Since he was a medical student, Dr Boller has always been interested in research and in dissemination of knowledge. He graduated summa cum laude with a thesis on the neurophysiology of REM sleep in animals. Following graduation, Dr. Boller’s initial area of interest was aphasia and related disorders; he later became primarily interested in cognitive disorders and in dementia.
He is particularly interested in the correlates of cognitive disorders with pathology, neurophysiology and imaging, and was one of the first to study the relation between Parkinson’s and Alzheimer’s disease, two processes that were thought to be unrelated.
His current areas of interest include cognitive changes related to such different conditions as age, brain injuries and air pollution. He is also interested in the history of Neurosciences and is Past President of the International Society for the History of Neurosciences.
He was the founding Editor-in-Chief of the European Journal of Neurology, the official Journal of the European Federation of Neurological Societies (now European Academy of Neurology).
He is co-Series Editor of the Handbook of Clinical Neurology, the leading reference in the field. He is a Fellow of the American Academy of Neurology and a member of the American Neurological Association. In addition, he has been an officer for the International Neuropsychological Society, for the International Neuropsychology Symposium and for the World Federation of Neurology (WFN).
Viviane Kovess Masfety,
is a psychiatrist and epidemiologist.
After finishing her medical studies in France, she completed her training at Mc Gill University in psychiatric research and transcultural psychiatry and she is a Mc Gill associated professor.
She co created the Psychosocial research Unit at Douglas Hospital (Montréal) where she was a FRSQ researcher for years working on mental health epidemiologic surveys.
She is the author of various international publications and the editor of an international review of psychiatric epidemiology (SPPE).
Her fields of interest have been: psychiatric epidemiology methodology, urban/rural comparisons, services research, international and European comparisons, among them gender and school children mental health.
She is the President of the Public Health Epidemiology section in the World Psychiatric Association, and a guest professor at the Mailman School of Public Health in Columbia University.
She has been the PI in a EU funded report on mental health in the European Union (ESEMED) which is the European part of a worldwide consortium of survey leaded by R.Kessler (Harvard and WHO) , she is leading the religion and use of care work group .
She has been the head director of the epidemiology and biostatistics department at the EHESP (Ecole des Hautes Etudes en Santé Publique) and the head of a PhD students supervisor at Paris Descartes University (EA4069) “Epidemiology, Evaluation and Health policies”.
She leaded a governmental expert group on stress and mental health and has been the designer of the French plan for Mental health and Psychiatry in France.
She is also a member of the French Haut Conseil en Santé Publique an institution, which aims to advice health policies in France.
Dr. Véronique Narboni,
studied Medicine in Montpellier, France.
She graduated in 1991 as a General Practitioner. She began her career in the pharmaceutical industry with Pierre Fabre in Castres, first as a Medical Advisor, then as Medical & Product Manager working with psychotropic medication.
She moved to Scandinavia in 1995 to work for Lundbeck. She was involved in the development of the Lundbeck International Psychiatric Institute and worked on the development of new international tools to train psychiatrists from across the globe and share best practices in CNS.
In 1999, she became a Guest Researcher at the Karolinska Institute in Stockholm, joining the National Swedish and Stockholm County Centre founded in 1993 by Professor Danuta Wasserman. She collaborated in the development of the WHO project SUPRE, including the leaflet on “Preventing suicide: a resource for school-teachers and other school staff”.
She then focused her attention on the impact of educational programmes on the attitudes and behaviour of general practitioners with regard to suicide prevention.
In 2000, she moved back to France where she spent several years as the President of the Lilly Institute in Paris.
In 2006 she turned her attention to international communications agencies, first as Medical Director for EURO RSCG (Havas group) and then as Global Medical Strategy Director for PHCG (Publicis Group).
In 2012, she became the Managing Director of HAPPYneuron a start-up specialized in Brain training. In 2015, she shares her time between her GP practice in Paris and her consulting activities with All About Brain Connections (A2BC) and Sustainable Brain Health Institute (SBHI).
Xenia Theodotou Schneider,
has a multidisciplinary background in Computer Science and Business Administration and she specialises in business strategy, innovation and knowledge management.
She has worked for 10 years in the pharmaceutical and biotechnology industries reengineering their processes.
She is an independent consultant of business strategy and the founder of XPRO Consulting Limited.
She is an adjunct professor of Business Strategy and Change Management at Ecole Supérieur de Commerce a Pau.
Since 2007 Xenia is an independent expert evaluator and technical auditor of innovative EU-funded projects in the scientific areas of information technology, environment and biotechnology.
She has participated in several EU-funded environmental projects for facilitating the science-policy-industry communication and knowledge transfer.
Also, she is the National Representative of Cyprus in the European Cooperation in Science and Technology (COST) Programme for the action “Interdisciplinarity in Research Programming and Funding Cycles”.
She has a multicultural background and working experience in several European countries.
She speaks English, Greek, Danish, Italian and French.
Charles Marciano is an Alumnus of the Maimonides School (1956-1960: 4th level to BAC) and a Pharmacist Biologist.
He holds a PHD in Pharmaceutical Science, a Diploma from the Institute of Industrial Pharmacy and an Executive MBA from HEC.
Over the course of Charles’ illustrious career, he has assumed senior level responsibilities in Operations and other functions in pharmaceutical companies including in R & D, Marketing, Sales, Management, Production, Regulatory Affairs and Pharmacy.
He was CEO of SCAT laboratories from 1979 to 1986 and President of Leo Pharma-France from 1986 to 2006.
Charles has been a Member of the Board of Directors of LEEM, a Member of the Board of Trustees of the Institute (IFIS) Health Industries, Founding President of the MERI Association and is currently its Honorary President.
MERI is recognized as a key forum with all national decision makers in health. Charles is also a Member of the Board of Directors of ORT.
In recognition of Charles' dedication and leadership, he has received the prestigious Order of Agricultural Merit and the Prince Henrik of Denmark Medal. Charles is also a Knight of the Legion of Honor.
Charles is currently the Coordinator of the Collective Works devoted to the the Pharmaceutical Industry Trade (Research and Development, Pharmaceutical Regulation, Marketing).